Bartosik-Psujek H - Search Results

1

Cladribine tablets versus other disease-modifying oral drugs in achieving no evidence of disease activity (NEDA) in multiple sclerosis-A systematic review and network meta-analysis.

Bartosik-Psujek H, Kaczyński Ł, Górecka M, Rolka M, Wójcik R, Zięba P, Kaczor M. Bartosik-Psujek H, et al. Mult Scler Relat Disord. 2021 Apr;49:102769. doi: 10.1016/j.msard.2021.102769. Epub 2021 Jan 16. Mult Scler Relat Disord. 2021. PMID: 33516133

2

[The assessment of development of binding antibodies to interferon beta during interferon beta 1a treatment of multiple sclerosis].

Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Rejdak K, Dobosz B, Stelmasiak Z. Bartosik-Psujek H, et al. Neurol Neurochir Pol. 2003;37(4):799-809. Neurol Neurochir Pol. 2003. PMID: 14746240 Polish.

3

Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine.

Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Dobosz B, Stelmasiak Z. Bartosik-Psujek H, et al. Acta Neurol Scand. 2004 Jun;109(6):390-2. doi: 10.1111/j.1600-0404.2004.00259.x. Acta Neurol Scand. 2004. PMID: 15147461 Clinical Trial.

4

[Development of binding antibodies to interferon-beta during treatment of multiple sclerosis with different types of interferon-beta].

Bartosik-Psujek H, Mitosek-Szewczyk K, Belniak E, Stelmasiak Z. Bartosik-Psujek H, et al. Pol Merkur Lekarski. 2004 Jul;17(97):28-32. Pol Merkur Lekarski. 2004. PMID: 15559606 Clinical Trial. Polish.

5

Paraoxonase 1 activity in different types of multiple sclerosis.

Jamroz-Wisniewska A, Beltowski J, Stelmasiak Z, Bartosik-Psujek H. Jamroz-Wisniewska A, et al. Mult Scler. 2009 Mar;15(3):399-402. doi: 10.1177/1352458508098371. Epub 2008 Oct 9. Mult Scler. 2009. PMID: 18845659

6

Impact of cladribine on soluble adhesion molecules in multiple sclerosis.

Mitosek-Szewczyk K, Stelmasiak Z, Bartosik-Psujek H, Belniak E. Mitosek-Szewczyk K, et al. Acta Neurol Scand. 2010 Dec;122(6):409-13. doi: 10.1111/j.1600-0404.2010.01330.x. Acta Neurol Scand. 2010. PMID: 20175758

7

Intravascular lymphoma mimicking multiple sclerosis.

Kloc G, Budziak M, Więckiewicz A, Pleśniak M, Bartosik-Psujek H. Kloc G, et al. Neurol Neurochir Pol. 2016 Jul-Aug;50(4):313-7. doi: 10.1016/j.pjnns.2016.04.007. Epub 2016 Apr 26. Neurol Neurochir Pol. 2016. PMID: 27375151

8

Severe disease exacerbation in a patient with neuromyelitis optica spectrum disorder during treatment with dimethyl fumarate.

Popiel M, Psujek M, Bartosik-Psujek H. Popiel M, et al. Mult Scler Relat Disord. 2018 Nov;26:204-206. doi: 10.1016/j.msard.2018.09.011. Epub 2018 Sep 12. Mult Scler Relat Disord. 2018. PMID: 30268042

9

Profile of Polish patients with primary progressive multiple sclerosis.

Brola W, Sobolewski P, Żak M, Flaga S, Fudala M, Siutka D, Kapica K, Chorąży M, Kułakowska A, Perenc A, Bartosik-Psujek H, Psujek M, Głąbiński A, Pawełczyk M, Gacek S, Potemkowski A. Brola W, et al. Mult Scler Relat Disord. 2019 Aug;33:33-38. doi: 10.1016/j.msard.2019.05.009. Epub 2019 May 21. Mult Scler Relat Disord. 2019. PMID: 31146082

10

Clinical and epidemiological characteristics of multiple sclerosis patients receiving disease-modifying treatment in Poland.

Kapica-Topczewska K, Collin F, Tarasiuk J, Chorąży M, Czarnowska A, Kwaśniewski M, Brola W, Bartosik-Psujek H, Adamczyk-Sowa M, Kochanowicz J, Kułakowska A. Kapica-Topczewska K, et al. Neurol Neurochir Pol. 2020;54(2):161-168. doi: 10.5603/PJNNS.a2020.0020. Epub 2020 Mar 27. Neurol Neurochir Pol. 2020. PMID: 32219813 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page